FDA Inspection 1022647 — Sanjeet S. Dadwal
The FDA completed an inspection of Sanjeet S. Dadwal on August 8, 2017 in Duarte, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 8, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Duarte, CA (United States)
Additional Details
Clinical Investigator (CI)